Loading...

CannBioRx Life Sciences Corp.

ATNFWNASDAQ
HealthcareMedical - Pharmaceuticals
$0.008
$0.00(2.53%)

CannBioRx Life Sciences Corp. ATNFW Peers

See (ATNFW) competitors and their performances in Stock Market.

Peer Comparison Table: Medical - Pharmaceuticals Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
ATNFW$0.01+2.53%5.5MN/AN/AN/A
INSM$66.36-2.44%12.1B-11.19-$5.93N/A
WBA$11.19-0.18%9.7B-1.67-$6.69+4.47%
ONC$240.41+0.88%2.1B-65.87-$3.65N/A
LFMDP$24.34-0.45%1.1B-10.79-$2.26N/A
HROWM$26.16-0.08%960.1MN/AN/A+11.33%
HROWL$25.20-0.32%924.8MN/AN/AN/A
LFMD$11.46-0.69%520.8M-34.73-$0.33N/A
HITI$2.23-2.19%180.5M-37.17-$0.06N/A
PETS$3.78+0.27%78.1M378.00$0.01N/A
Showing 1 to 10 of 21 results
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

ATNFW vs INSM Comparison

ATNFW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ATNFW stands at 5.5M. In comparison, INSM has a market cap of 12.1B. Regarding current trading prices, ATNFW is priced at $0.01, while INSM trades at $66.36.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ATNFW currently has a P/E ratio of N/A, whereas INSM's P/E ratio is -11.19. In terms of profitability, ATNFW's ROE is -1.47%, compared to INSM's ROE of -4.47%. Regarding short-term risk, ATNFW is less volatile compared to INSM. This indicates potentially lower risk in terms of short-term price fluctuations for ATNFW.

Stock Price Comparison

Loading...

Frequently Asked Questions